Firdapse (amifampridine) / BioMarin, Catalyst Pharma  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Firdapse (amifampridine) / BioMarin, Catalyst Pharma
EAP-001, NCT02189720: Expanded Access Study Amifampridine Phosphate in Congenital Myasthenic Syndrome (CMS)

No Longer Available
N/A
US
Amifampridine Phosphate, 3,4-Diaminopyridine Phosphate, 3,4 DAP
Catalyst Pharmaceuticals, Inc.
Congenital Myasthenic Syndrome
 
 

Download Options